BRCA2 and familial pancreatic carcinoma: Moreover, the relative risk (RR) and cumulative incidence of pancreatic cancer for germline BRCA2 pathogenic variants are 3.5–10 and 2%–7%, and for germline BRCA1 pathogenic variants, 2.26 and 1%–3%, respectively [14].